CVE-ID |
CVE-2020-10627
|
• CVSS Severity Rating • Fix Information • Vulnerable Software Versions • SCAP Mappings • CPE Information
|
Description |
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
|
References |
Note: References are provided for the convenience of the reader to help distinguish between vulnerabilities. The list is not intended to be complete.
|
|
Assigning CNA |
ICS-CERT |
Date Record Created |
20200316 |
Disclaimer: The record creation date may reflect when
the CVE ID was allocated or reserved, and does not
necessarily indicate when this vulnerability was
discovered, shared with the affected vendor, publicly
disclosed, or updated in CVE.
|
Phase (Legacy) |
Assigned (20200316) |
Votes (Legacy) |
|
Comments (Legacy) |
|
Proposed (Legacy) |
N/A |
This is an record on the CVE List, which provides common identifiers for publicly known cybersecurity vulnerabilities. |
|
For More Information: CVE Request Web Form (select "Other" from dropdown)
|